Sandoz plans $300 million biosimilar facility in Ljubljana
Sandoz Group plans to invest around $300 million to build a new biosimilar manufacturing facility in Ljubljana, Slovenia. The facility is expected to start operations in 2029 and add 8,000 litres of production capacity.